0000899243-18-031591.txt : 20181221
0000899243-18-031591.hdr.sgml : 20181221
20181221161953
ACCESSION NUMBER: 0000899243-18-031591
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181219
FILED AS OF DATE: 20181221
DATE AS OF CHANGE: 20181221
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SV LIFE SCIENCES FUND IV, L.P.
CENTRAL INDEX KEY: 0001367381
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36830
FILM NUMBER: 181249765
BUSINESS ADDRESS:
STREET 1: ONE BOSTON PLACE
STREET 2: 201 WASHINGTON STREET, SUITE 3900
CITY: BOSTON
STATE: MA
ZIP: 02108
BUSINESS PHONE: 617-367-8100
MAIL ADDRESS:
STREET 1: ONE BOSTON PLACE
STREET 2: 201 WASHINGTON STREET, SUITE 3900
CITY: BOSTON
STATE: MA
ZIP: 02108
FORMER NAME:
FORMER CONFORMED NAME: SV LIFE SCIENCES FUND IV LP
DATE OF NAME CHANGE: 20060623
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.
CENTRAL INDEX KEY: 0001392309
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36830
FILM NUMBER: 181249766
BUSINESS ADDRESS:
STREET 1: ONE BOSTON PLACE
STREET 2: 201 WASHINGTON STREET, SUITE 3900
CITY: BOSTON
STATE: MA
ZIP: 02108
BUSINESS PHONE: 617-367-8100
MAIL ADDRESS:
STREET 1: ONE BOSTON PLACE
STREET 2: 201 WASHINGTON STREET, SUITE 3900
CITY: BOSTON
STATE: MA
ZIP: 02108
FORMER NAME:
FORMER CONFORMED NAME: SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS L P
DATE OF NAME CHANGE: 20070307
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SV Life Sciences Fund IV (GP), L.P.
CENTRAL INDEX KEY: 0001422340
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36830
FILM NUMBER: 181249767
BUSINESS ADDRESS:
STREET 1: ONE BOSTON PLACE
STREET 2: 201 WASHINGTON STREET, SUITE 3900
CITY: BOSTON
STATE: MA
ZIP: 02108
BUSINESS PHONE: 617-367-8100
MAIL ADDRESS:
STREET 1: ONE BOSTON PLACE
STREET 2: 201 WASHINGTON STREET, SUITE 3900
CITY: BOSTON
STATE: MA
ZIP: 02108
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SVLSF IV, LLC
CENTRAL INDEX KEY: 0001422339
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36830
FILM NUMBER: 181249768
BUSINESS ADDRESS:
STREET 1: ONE BOSTON PLACE
STREET 2: 201 WASHINGTON STREET, SUITE 3900
CITY: BOSTON
STATE: MA
ZIP: 02108
BUSINESS PHONE: 617-367-8100
MAIL ADDRESS:
STREET 1: ONE BOSTON PLACE
STREET 2: 201 WASHINGTON STREET, SUITE 3900
CITY: BOSTON
STATE: MA
ZIP: 02108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: KalVista Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001348911
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 200915291
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0430
BUSINESS ADDRESS:
STREET 1: ONE KENDALL SQUARE
STREET 2: BUILDING 200, STE. 2203
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: (857) 999-0075
MAIL ADDRESS:
STREET 1: ONE KENDALL SQUARE
STREET 2: BUILDING 200, STE. 2203
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Carbylan Therapeutics, Inc.
DATE OF NAME CHANGE: 20140916
FORMER COMPANY:
FORMER CONFORMED NAME: Carbylan Biosurgery, Inc
DATE OF NAME CHANGE: 20130102
FORMER COMPANY:
FORMER CONFORMED NAME: Carbylan Biosurgery Inc
DATE OF NAME CHANGE: 20060105
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-12-19
0
0001348911
KalVista Pharmaceuticals, Inc.
KALV
0001422339
SVLSF IV, LLC
ONE BOSTON PLACE
201 WASHINGTON STREET, SUITE 3900
BOSTON
MA
02108
0
0
1
0
0001422340
SV Life Sciences Fund IV (GP), L.P.
ONE BOSTON PLACE
201 WASHINGTON STREET, SUITE 3900
BOSTON
MA
02108
0
0
1
0
0001392309
SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.
ONE BOSTON PLACE
201 WASHINGTON STREET, SUITE 3900
BOSTON
MA
02108
0
0
1
0
0001367381
SV LIFE SCIENCES FUND IV, L.P.
ONE BOSTON PLACE
201 WASHINGTON STREET, SUITE 3900
BOSTON
MA
02108
0
0
1
0
Common Stock
2018-12-19
4
S
0
2077
20.018
D
2506202
D
Common Stock
2018-12-19
4
S
0
59
20.018
D
71152
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.16, inclusive. The Reporting Persons undertake to provide to the Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
These shares are held directly by SVLS IV LP.
SVLS IV LP and Strategic Partners (each a "Fund", or collectively the "Funds") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliates. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein. SVLS IV GP, the general partner of the Funds, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLS IV GP disclaims beneficial ownership of shares held by the Funds, except to the extent of any pecuniary interest therein. SVLSF IV, LLC, the general partner of SVLS IV GP, may be deemed to share voting and dispositive power over the shares held by the Funds. SVLSF IV, LLC disclaims beneficial ownership of shares held by the Funds except to the extent of any pecuniary interest therein.
These shares are held directly by Strategic Partners.
This statement is filed by: (i) SV Life Sciences Fund IV, L.P. ("SVLS IV LP") and SV Life Sciences Fund IV Strategic Partners, L.P. ("Strategic Partners"), each a Delaware limited partnership and direct owners of the shares of Common Stock of the Issuer (together, the "Shares"); (ii) SV Life Sciences Fund IV (GP), L.P., a Delaware limited partnership ("SVLS IV GP") and general partner of SVLS IV LP and Strategic Partners; and (iii) SVLSF IV, LLC, a Delaware limited liability company and general partner of SVLS IV GP. Each of SVLS IV LP, Strategic Partners, SVLS IV GP and SVLSF IV, LLC are sometimes individually referred to herein as a "Reporting Person" and collectively as the "Reporting Persons."
/s/Denise Marks
2018-12-21